Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05430230 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 2026 to Jun 2027
    • Study completion date: Sep 1, 2026 to Sep 1, 2027
    v5
  2. Primary completion date: Dec 2024 to Jun 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Mar 1, 2025 to Sep 1, 2026
    • Site details revised
    v4
  3. Primary completion date: Jul 2023 to Dec 2024
    • Study completion date: Sep 1, 2023 to Mar 1, 2025
    v3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 7 more changesShow less
    • Enrollment target: 12 to 20
    • Primary endpoint revised
    • Start date changed from estimate of Jul 2022 to Aug 24, 2022
    • Eligibility criteria expanded, about 62 words
    • Study description revised
    • Site details revised
    • Study title shortened, about 2 words
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a pilot study with a 4-period double-cross-over design evaluating a treatment with non-steroidal anti-inflammatory drugs (NSAIDs) in people with painful knee osteoarthritis.
Trial Details
NCT Number NCT05430230
Lead Sponsor Northwestern University
Conditions
(from sponsor)		 Osteoarthritis, Knee
Related terms Osteoarthritis, Osteoarthritis, Knee
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov